Chemtura, the specialty chemical manufacturer, has returned in excess of 50% over the past twelve months, and analysts’ average price target indicates there’s still a 24% upside to be had. Longbow Research—who holds a Buy rating on the stock—said it best when analyzing the crux of this company’s bullish thesis, citing its “acquisition of Solaris’ bromine assets, a reinvigorated AgroSolutions pipeline, and an eventual divestiture of its consumer products” as key reasons to be optimistic.
Google, lastly, has made headlines of late for cracking the $800 mark for the first time since its 2004 IPO. Now trading slightly off their all-time high, many tech players are wondering what to do with the stock. While it may be tempting for some long-term investors to take their gains, Google still represents a nice ‘growth at a reasonable price’ play. At 14.8 times forward earnings and 3.6 times book, shares are at a slight discount to industry averages, and the sell-side’s forecasted EPS growth—17-18% next year—trumps even what’s expected of Apple by about four percentage points.
Click here to learn more about Insider Monkey’s Hedge Fund Newsletter
Insider Monkey’s small-cap strategy returned 25.4% between September 2012 and January 2013 versus 7.4% for the S&P 500 index. Try it now by clicking the link above.
Disclosure: none